Rejuvenate Biomed completes enrollment in sarcopenia trial (opens in new tab)

Phase 2 study will assess whether RJx-01 can improve muscle function in patients with COPD-induced sarcopenia. Muscle loss rarely arrives alone – frailty, hospitalization and lost independence tend to follow, alongside the assumption that physical decline is simply the price of a long life. Rejuvenate Biomed is among those who disagree. The Belgium-based company has […] The post appeared first on <a href="